Siddarth Selvaraj

Arima Genomics (United States)

Associate Professor(heuristic)

Genomics and Chromatin Dynamics · Molecular Biology

h-index19

i10-index22

Publications36

Citations18,407

Grants

11 total · 0 active

NIH #5R44CA247185-04

Developing a kit-based research use only (RUO) translocation assay for deployment as a lab developed test (LDT) toward changing outcomes for patients with driver-negative tumors

Amount: $1.9M
Period: 2020-05-01 → 2025-04-30
PIs: 1
Est. capacity / PI: ~0 students

Awarded at ARIMA GENOMICS, INC.

NIH #2R44CA247185-03A1

Developing a kit-based research use only (RUO) translocation assay for deployment as a lab developed test (LDT) toward changing outcomes for patients with driver-negative tumors

Amount: $2.1M
Period: 2020-05-01 → 2025-04-30
PIs: 1
Est. capacity / PI: ~0 students

Awarded at ARIMA GENOMICS, INC.

NIH #5R44CA247185-02

Commercialization of a highly-sensitive, scalable and low-input compatible kit-based solution for discovery of translocations from FFPE tumor biopsies

Amount: $999K
Period: 2020-05-01 → 2022-02-28
PIs: 1
Est. capacity / PI: ~0 students

Awarded at ARIMA GENOMICS, INC.

Student capacity is a rough estimate from remaining award size, split equally among PIs. Actual funding decisions vary.

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

Potential Collaborators

Recent Publications

Last 2 years · showing 1 of 1

Hi-C sequencing to identify clinically actionable fusions in non–small cell lung cancer missed by other sequencing technologies.
Journal of Clinical Oncology · 2026-05-28

Open author page on OpenAlex →

Siddarth Selvaraj

Grants

Developing a kit-based research use only (RUO) translocation assay for deployment as a lab developed test (LDT) toward changing outcomes for patients with driver-negative tumors

Developing a kit-based research use only (RUO) translocation assay for deployment as a lab developed test (LDT) toward changing outcomes for patients with driver-negative tumors

Commercialization of a highly-sensitive, scalable and low-input compatible kit-based solution for discovery of translocations from FFPE tumor biopsies

All Grants

Developing a kit-based research use only (RUO) translocation assay for deployment as a lab developed test (LDT) toward changing outcomes for patients with driver-negative tumors

Developing a kit-based research use only (RUO) translocation assay for deployment as a lab developed test (LDT) toward changing outcomes for patients with driver-negative tumors

Commercialization of a highly-sensitive, scalable and low-input compatible kit-based solution for discovery of translocations from FFPE tumor biopsies

Commercialization of a highly-sensitive, scalable and low-input compatible kit-based solution for discovery of translocations from FFPE tumor biopsies

Commercialization of HaploSeq as a Service (HaaS) for generating chromosome-span phased genome and exome sequence information

Commercialization of HaploSeq as a Service (HaaS) for generating chromosome-span phased genome and exome sequence information

Commercialization of a low-cost user-friendly DNA preparation kit that produces chromosome-span contiguity from conventional short-read sequencing for a wide range of applications

Commercialization of a low-cost user-friendly DNA preparation kit that produces chromosome-span contiguity from conventional short-read sequencing for a wide range of applications

Maximal resolution and full-length phasing for next-generation MHC-typing

Maximal resolution and full-length phasing for next-generation MHC-typing

Non-invasive determination of complete fetal genomes from cfDNA using HaploSeq

Career Trajectory

Research Cluster Map

Potential Collaborators

Recent Publications